Elevance Health lifts outlook. Elevance Health stock costs EUR 395.75 at USD 94.2 billion value

Published on 10/23/2026 at 11:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter revenue reached USD 51.43 billion, up 1.40 percent year over year. Elevance Health stock costs EUR 395.75 on October 23, 2026.

Guidance, results and shareholder returns

Adjusted diluted earnings guidance reached at least USD 29.00 for fiscal year 2026.
Third-quarter operating revenue rose 0.70 percent to USD 50.4 billion.
Elevance Health stock trades at EUR 395.75 at 11:18 a.m. CEST at Lang & Schwarz on October 23, 2026.
The quarterly dividend declared on October 20, 2026, was USD 1.72 per share.

Modernes Krankenhaus-Campus mit Glasfassade und Patienten im Eingangsbereich — Elevance Health Krankenversicherungs-Campus US2855211023 zeigt modernen Gebäudeeingang mit weitläufiger Grünanlage unter blauem Himmel, Illustration mit AI erstellt.

Elevance Health (US0367521038) traded at EUR 395.75 at Lang & Schwarz on October 23, 2026, at 11:18 a.m. CEST. The insurer raised its fiscal 2026 adjusted diluted earnings guidance to at least USD 29.00 after reporting third-quarter results on October 21, 2026, according to Business Wire.

Revenue growth stays measured

Operating revenue reached USD 50.4 billion in the third quarter of 2026, up 0.70 percent from USD 50.1 billion in the third quarter of 2025. Total revenue increased 1.40 percent to USD 51.43 billion, while shareholders' net income rose 14.80 percent to USD 1.365 billion, the company release said.

GAAP diluted earnings per share came to USD 6.27, compared with USD 5.32 a year earlier. Adjusted diluted earnings per share were USD 6.99, and the release said the quarter included a USD 1.85 per-share net non-operating benefit.

What does the margin mix mean?

The operating margin was 2.50 percent in the third quarter of 2026, down from 2.60 percent a year earlier. Health Benefits produced a 1.00 percent margin, compared with 1.40 percent in the prior-year quarter, while Carelon reached 4.70 percent against 4.20 percent, according to Business Wire. The figures show a mixed operating picture: the Carelon businesses provided the stronger margin contribution, while Health Benefits remained under pressure.

Three recent company milestones

On October 20, 2026, Elevance Health declared a fourth-quarter dividend of USD 1.72 per share. On October 21, 2026, the company reported USD 50.4 billion in third-quarter operating revenue and raised its adjusted earnings outlook to at least USD 29.00. On October 22, 2026, Elevance Health stock last traded at USD 446.25 on its US listing, according to a dated market report.

Two dates for shareholders

The fourth-quarter dividend has a December 4, 2026, record date and a December 18, 2026, payment date, according to Business Wire. The dates give shareholders the next concrete calendar markers after the earnings release.

Stock remains tied to guidance

Elevance Health's raised outlook provides the clearest near-term reference point for the stock. Management also raised operating cash flow guidance to at least USD 6.5 billion for fiscal year 2026, while medical membership stood at 44.9 million as of September 30, 2026, down 1.10 percent from a year earlier.

Elevance Health stock was trading at EUR 395.75 at Lang & Schwarz on October 23, 2026, at 11:18 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Elevance Health stock.